In a recent study, in which 37% had concomitant T2D, MR-proANP was associated with clinical outcomes in HFpEF, not in HFrEF, supporting the use of MR-proANP as a prognostic marker in patients with HFpEF [9]. Here, NPPA is linked to type 2 diabetes mellitus.